Title: An allosteric redox switch in domain V of β2-glycoprotein I controls membrane binding and anti-domain I autoantibody recognition

Journal Article · · Journal of Biological Chemistry

Not Available

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE; USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities Division
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1804127
Journal Information:
Journal of Biological Chemistry, Journal Name: Journal of Biological Chemistry Journal Issue: 2 Vol. 297; ISSN 0021-9258
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (57)

How do antiphospholipid antibodies bind ?2-glycoprotein I? journal August 2003
Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β 2 ‐glycoprotein I journal August 2011
Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope journal November 2011
Bioorthogonal Chemistry Enables Single‐Molecule FRET Measurements of Catalytically Active Protein Disulfide Isomerase journal September 2020
Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of β2-glycoprotein I journal March 2010
Phospholipid-Bound β2-Glycoprotein I Induces the Production of Anti-Phospholipid Antibodies journal August 2000
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor journal June 1990
Measuring and increasing protein stability journal January 1990
The use of fluorescence methods to monitor unfolding transitions in proteins journal February 1994
Solution Structure of Human and Bovine β2-Glycoprotein I Revealed by Small-angle X-ray Scattering journal August 2002
Simultaneous characterization of SNPs and N-glycans from multiple glycosylation sites of intact β-2-glycoprotein-1 (B2GP1) by ESI-qTOF-MS journal June 2019
Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS) journal December 2011
Redox Control of Platelet Aggregation † journal January 2003
Toward Understanding Tryptophan Fluorescence in Proteins journal June 1998
Pathogenesis of antiphospholipid syndrome: understanding the antibodies journal May 2011
Fibrinogen function achieved through multiple covalent states journal October 2020
Specific domain V reduction of beta-2-glycoprotein I induces protein flexibility and alters pathogenic antibody binding journal February 2021
The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion journal December 1987
Effect of Heparin on the Activation of Factor XII and the Contact System in Plasma journal January 1991
The Pathogenesis of the Antiphospholipid Syndrome journal March 2013
Anti- 2 glycoprotein I ( 2GPI) autoantibodies recognize an epitope on the first domain of  2GPI journal December 1998
Heparin Inhibits the Binding of β2-glycoprotein I to Phospholipids and Promotes the Plasmin-mediated Inactivation of This Blood Protein journal January 2002
The Local Phospholipid Environment Modulates the Activation of Blood Clotting journal March 2007
The J-elongated conformation of β2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome journal July 2020
Allosteric disulfides: Sophisticated molecular structures enabling flexible protein regulation journal January 2019
Adhesion mechanism of human beta 2-glycoprotein I to phospholipids based on its crystal structure journal October 1999
Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome journal November 1999
ATSAS 2.8 : a comprehensive data analysis suite for small-angle scattering from macromolecular solutions journal June 2017
Redox control of β 2 -glycoprotein I-von Willebrand factor interaction by thioredoxin-1: Reduced β 2 GPI and von Willebrand factor journal August 2010
Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I: Post-translational modification of beta 2 glycoprotein I journal July 2011
β2-Glycoprotein I: evolution, structure and function: β2-Glycoprotein I journal July 2011
β 2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions journal June 2013
Autoregulation of von Willebrand factor function by a disulfide bond switch journal February 2018
Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic Coronary Artery Disease journal November 2020
Platelet Protein Disulfide Isomerase Promotes Glycoprotein Ibα–Mediated Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions journal March 2019
Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation journal January 2017
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosis journal February 2005
Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change journal March 2006
β2-Glycoprotein I inhibits von Willebrand factor–dependent platelet adhesion and aggregation journal September 2007
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers journal September 2008
Naturally occurring free thiols within β2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress–induced cell injury journal September 2010
β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome journal August 2010
Beta 2 glycoprotein I is a substrate of thiol oxidoreductases journal September 2010
β2-Glycoprotein I: a novel component of innate immunity journal June 2011
In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions journal October 2011
Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation journal June 2012
The significance of autoantibodies against β2-glycoprotein I journal July 2012
A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome journal May 2014
Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS journal July 2014
Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS journal January 2020
beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway journal November 1985
Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies journal May 2018
Discovery and characterization of 2 novel subpopulations of aPS/PT antibodies in patients at high risk of thrombosis journal June 2019
The purification of reduced β2-glycoprotein I showed its native activity in vitro journal September 2017
Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome journal October 2017
Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode journal March 2016
Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I journal August 2020